2,220 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
GILD Gilead Sciences, Inc. $72.78 $94.35B Downtrend
Article Searches
GSK Prescribes A $3.5bn Bond In 3 Parts https://seekingalpha.com/article/4250143-gsk-prescribes-3_5bn-bond-3-parts?source=feed_all_articles Mar 21, 2019 - British pharma giant GlaxoSmithKline joined the recent groundswell of high-grade corporate bond issuers Monday to sell new debt.The UK-based firm priced US$3.5bn worth of ‘A’-rated, three-, five- and
IPO Update: Precision BioSciences Readies Plan For IPO https://seekingalpha.com/article/4249820-ipo-update-precision-biosciences-readies-plan-ipo?source=feed_tag_ipo_analysis Mar 19, 2019 - Precision BioSciences intends to raise $126.4 million in an IPO of its common stock.The firm is developing a gene editing platform for disease treatments, research, and crop modification applications.
IPO Update: Genfit Files Proposed Terms For IPO And Private Placement https://seekingalpha.com/article/4249748-ipo-update-genfit-files-proposed-terms-ipo-private-placement?source=feed_tag_ipo_analysis Mar 19, 2019 - Genfit S.A. is aiming to raise $130 million in a global IPO and European private placement.The firm is in late-stage trials for its primary treatment candidate for NASH.While its Elafibranor candidate
GILD: BMO Capital Markets starts at Outperform http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=UD20190315120136 Mar 15, 2019 - BMO Capital Markets issues rating change for GILD
If You Gild It, Will They Come? https://www.nytimes.com/2019/03/13/style/hudson-yards-shopping.html?partner=rss&emc=rss Mar 14, 2019 - A brand-new vertical retail palace — don’t call it a mall — opens at Hudson Yards, New York’s biggest, shiniest new multibillion-dollar development. Will crowds follow?
Agenus Wins $7.5M Milestone Payment From Gilead, Stock Up http://www.zacks.com/stock/news/359597/agenus-wins-%2475m-milestone-payment-from-gilead-stock-up?cid=CS-ZC-FT-359597 Mar 14, 2019 - Agenus (AGEN) gets a $7.5-million milestone payment from Gilead following the FDA acceptance of the company's IND filing for AGEN1423. Shares rise.
Precision Sets Itself Up For An IPO, With An Already Impressive Partnership On The Table https://seekingalpha.com/article/4247541-precision-sets-ipo-already-impressive-partnership-table?source=feed_tag_ipo_analysis Mar 09, 2019 - Precision BioSciences is expected to do an IPO soon that is expected to be valued at $100 million.The genome editing ARCUS technology platform offers a lot of potential using a fully synthetic enzyme
Gilead Reports Positive Data on HIV Drugs Biktarvy & Descovy http://www.zacks.com/stock/news/358436/gilead-reports-positive-data-on-hiv-drugs-biktarvy-descovy?cid=CS-ZC-FT-358436 Mar 08, 2019 - Gilead (GILD) presents encouraging data on two leading HIV regimens, Bikatrvy and Descovy.
Gilead Reports Positive Data on HIV Drugs Biktarvy & Descovy http://www.zacks.com/stock/news/358194/gilead-reports-positive-data-on-hiv-drugs-biktarvy-descovy?cid=CS-ZC-FT-358194 Mar 07, 2019 - Gilead (GILD) presents encouraging data on two leading HIV regimens, Bikatrvy and Descovy.
Road To Financial Independence: Rising Dividends And Endless Opportunities https://seekingalpha.com/article/4246322-road-financial-independence-rising-dividends-endless-opportunities?source=feed Mar 05, 2019 - Dividend income hit $279 in February, up 55% Y/Y and 17.2% sequentially.The big increase is heavily boosted by the first annual dividend from Siemens Healthineers which easily compensated for the exit

Pages: 123456...222

Page 1>

Related Companies

Name Exchange Price Mkt Cap
BIIB Biogen Inc. NASDAQ $334.44 $67.37B
AMGN Amgen Inc. NASDAQ $200.81 $129.98B
SGEN Seattle Genetics, Inc. NASDAQ $76.15 $12.09B
NBIX Neurocrine Biosciences, Inc. NASDAQ $117.38 $10.62B
QGEN Qiagen N.V. NASDAQ $37.42 $8.5B
Sector: Health Care > Industry: Biotechnology: Biological Products (No Diagnostic Substances)
DeepLinks for Gilead Sciences
GILD - Google Finance https://www.google.com/finance?q=GILD Industry related info and international coverage Summary News
GILD - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=GILD Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options